Nutex Health Announces 1-for-15 Reverse Stock Split Effective From April 10, 2024; Number Of Common Shares Outstanding Will Be Reduced From Approximately 745M To 50M Shares
Nutex Health Announces 1-for-15 Reverse Stock Split Effective From April 10, 2024; Number Of Common Shares Outstanding Will Be Reduced From Approximately 745M To 50M Shares
As a result of the reverse stock split, the number of common shares outstanding will be reduced from approximately 745 million shares to approximately 50 million shares, and the number of authorized shares of common stock will remain at 950 million shares. In addition, the number of shares reserved for issuance under the Company's equity compensation plan immediately prior to the reverse stock split will be reduced proportionately. Adjustments will also be made to the Company's outstanding warrants and stock options. The number of shares into which these securities are convertible or exercisable will be adjusted in line with the reverse split, as will the exercise prices of these securities.
由於反向股票拆分，已發行普通股的數量將從約7.45億股減少到約5000萬股，普通股的授權數量將保持在9.5億股。此外，在反向股票拆分前夕根據公司股權補償計劃預留的發行股票數量將按比例減少。還將對公司的未償認股權證和股票期權進行調整。這些證券可轉換或可行使的股票數量將根據反向拆分進行調整，這些證券的行使價格也將進行調整。
譯文內容由第三人軟體翻譯。